Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Bayesian reanalysis of early remdesivir for the treatment of COVID-19 in outpatients with high risk of progression to severe disease
Saved in:
| Published in: | PLOS ONE |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Bayesian reanalysis of early remdesivir for the treatment of COVID-19 in outpatients with high risk of progression to severe disease
- Remdesivir in COVID-19: A Focus on Pediatric Cardiac Patients
- Poldip2 deficiency attenuates lung disease severity in a mouse model of COVID-19
- The synergistic interaction between ACE and TMPRSS2 polymorphisms increases the risk of severe COVID-19
- Symptoms and Severity of COVID-19 in Patients with Immune-Mediated Inflammatory Diseases: Experience of a University Medical Center
- Identifying high-risk combinations of metformin during COVID-19
- Distinct plasma cytokine and chemokine profiles in severe COVID-19 and septic shock